B
1.02
-0.06 (-5.56%)
| Previous Close | 1.08 |
| Open | 1.11 |
| Volume | 1,213,130 |
| Avg. Volume (3M) | 957,259 |
| Market Cap | 20,288,616 |
| Price / Earnings (TTM) | 11.33 |
| Price / Sales | 6.28 |
| Price / Book | 8.50 |
| 52 Weeks Range |
| Profit Margin | 4.28% |
| Operating Margin (TTM) | -11.31% |
| Diluted EPS (TTM) | 0.090 |
| Quarterly Revenue Growth (YOY) | -1.00% |
| Quarterly Earnings Growth (YOY) | -36.70% |
| Total Debt/Equity (MRQ) | 74.26% |
| Current Ratio (MRQ) | 1.88 |
| Operating Cash Flow (TTM) | -1.42 M |
| Levered Free Cash Flow (TTM) | 11.22 M |
| Return on Assets (TTM) | -1.21% |
| Return on Equity (TTM) | 6.10% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Basel Medical Group Ltd | - | - |
AIStockmoo Score
1.3
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 3.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 1.25 |
|
Basel Medical Group Ltd provides general and subspecialized orthopedic, trauma and sports medicine services such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery and minimally invasive orthopedic procedures, as well as neurosurgical treatments. Key revenue is generated from Singapore. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| % Held by Insiders | 67.81% |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 26 Jun 2025 | Announcement | Basel Medical Obtains Waiver of Lock-Up for Potential Strategic Fund Raising |
| 29 May 2025 | Announcement | Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility |
| 22 May 2025 | Announcement | Basel Medical Group Ltd Enters into US$ 1.0 Billion Bitcoin (BTC) Purchase Agreement |
| 20 May 2025 | Announcement | Basel Medical Group Subsidiary Awarded S$375 Million Contract to Supply Healthcare Products; Group to Enhance AI-Powered Healthcare Supply Chain Capabilities |
| 16 May 2025 | Announcement | Basel Medical Group Ltd Kicks Off US$ 1.0 Billion Bitcoin (BTC) Acquisition Strategy Move |
| 30 Apr 2025 | Announcement | Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia |
| 11 Apr 2025 | Announcement | Basel Medical Group Signs Agreement to Acquire Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |